Structure-activity studies of 1H-pyrazolo[3,4-b]pyridine 1 have resulted in the discovery of potent CDK1/CDK2 selective inhibitor 21h, BMS-265246 (CDK1/cycB IC(50)=6 nM, CDK2/cycE IC(50)=9 nM). The 2,6-difluorophenyl substitution was critical for potent inhibitory activity. A solid state structure of 21j, a close di-fluoro analogue, bound to CDK2 shows the inhibitor resides coincident with the ATP purine binding site and forms important H-bonds with Leu83 on the protein backbone.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0960-894x(03)00381-0DOI Listing

Publication Analysis

Top Keywords

1h-pyrazolo[34-b]pyridine inhibitors
4
inhibitors cyclin-dependent
4
cyclin-dependent kinases
4
kinases highly
4
highly potent
4
potent 26-difluorophenacyl
4
26-difluorophenacyl analogues
4
analogues structure-activity
4
structure-activity studies
4
studies 1h-pyrazolo[34-b]pyridine
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!